Related by context. All words. (Click for frequent words.) 89 Receives FDA Clearance 88 Announces FDA Clearance 86 Gets FDA Clearance 84 FDA Approves 84 FDA Approvals 84 FDA Okays 84 Files IND 83 Completes Enrollment 83 Submits NDA 83 Receives Orphan Drug Designation 83 Completes Patient Enrollment 82 Initiates Clinical Trial 82 Receives Approvable Letter 81 Improves Survival 81 Drug Candidate 81 Announce License Agreement 81 FDA Clearance 81 Demonstrates Significant 81 Shows Promise 80 Drug Shows Promise 80 IND Application 80 Sign Licensing Agreement 80 FDA Accepts 80 Drug Fails 80 Significantly Improves 80 Develop Novel 80 Improves Outcomes 80 Reduces Risk 80 Meets Primary Endpoint 80 Shows Promising 79 Presents Positive 79 Announce Collaboration Agreement 79 Lupus Drug 79 Initiates Phase II 79 Begins Shipment 79 PRN FDA Approves 79 Molecular Diagnostic Test 79 Proven Effective 78 Achieves Milestone 78 Test Detects 78 Arthritis Drug 78 Shows Promise Against 78 Licenses Novel 78 Initiates Clinical Trials 78 Initiates Enrollment 78 Receives Milestone Payment 78 Awarded Patent 78 Receives Patent 78 Patient Enrollment 78 Generic Versions 78 ORLive Presents 78 Significantly Reduces 78 Announces Initiation 78 Initiates Clinical 78 Announces Tentative Approval 77 Initiates Dosing 77 Study Demonstrates 77 Osteoporosis Drug 77 Receives SFDA Approval 77 Patients Treated With 77 Sign License Agreement 77 Initiate Clinical Trial 77 Treatment Reduces 77 Commercializes 77 Rheumatoid Arthritis Drug 77 FDA Warns 77 Enrolls First 77 Submits Biologics License Application 77 Achieves Primary Endpoint 77 Single Dose 77 Demonstrates Positive 77 Adjuvant Treatment 77 Presents Preclinical Data 77 Patent Issued 77 Prostate Cancer Vaccine 77 Reduces Pain 77 Clinical Study Shows 77 BioSante Pharmaceuticals Announces 77 Blood Thinner 77 Clinical Trial Results 77 Mylan Receives Approval 77 Introduces Next Generation 77 Files Patent Application 77 Obtains FDA 77 Present Preclinical Data 77 Generic Version 77 Phase 2b Clinical Trial 76 Prolongs Survival 76 Taro Receives 76 Lowers Risk 76 AnaSpec Introduces 76 Psoriasis Drug 76 Demonstrates Potential 76 Introduces Novel 76 Begins Dosing 76 k Clearance 76 Improves Quality 76 Collaborators Present 76 Clinical Trial Evaluating 76 Investigational Compound 76 Reveals Positive 76 Commences Phase 76 Significantly Increases 76 Less Invasive 76 Phase IIb Trial 76 Prove Effective 76 Effectively Treats 76 Granted Orphan Drug 76 Proves Successful 76 Cholesterol Lowering Drug 76 Protects Against 76 Migraine Drug 76 Submits Supplemental 76 Receives CE Marking 76 Diagnostic Tests 76 Phase 2b Trial 76 Therapeutic Competitors Companies 76 Receives Orphan Drug 76 Successfully Treated 76 Advanced Melanoma 76 Expand Collaboration 76 Increases Risk 76 Holds Promise 76 Submits IND 76 Patients Undergoing 76 Helps Predict 76 Shows Efficacy 75 FDA Panel Recommends 75 Transdermal Patch 75 Launches Generic Version 75 Announces License Agreement 75 Breast Cancer Recurrence 75 Blood Pressure Drug 75 Expanded Indication 75 First Patient Treated 75 Receives Tentative Approval 75 NDA Submission 75 Study Showed 75 Appears Safe 75 Cholesterol Drug 75 Novel Oral 75 Announces Licensing Agreement 75 Data Suggest 75 Announce Licensing Agreement 75 Files Patent 75 Introduces Revolutionary 75 Phase III Trial 75 Receives Positive Opinion 75 Contrast Agent 75 Submits Application 75 Gout Drug 75 Could Predict 75 Study Evaluating 75 HER2 Positive 75 Develop Next Generation 75 Vaccine Adjuvant 75 Begins Shipping 75 Lung Cancer Drug 75 Successfully Tests 75 Receives Fast Track 75 Pivotal Study 75 Milestone Payment 75 Successfully Treats 75 Osteoporosis Treatment 75 Patent Covering 75 Could Detect 75 Non Invasive Treatment 75 Proves Effective 75 Topical Treatment 75 Drug Resistant 75 Receives Positive 74 Epilepsy Drug 74 Phase III Clinical Trial 74 Announces Immediate Availability 74 Successfully Completes Phase 74 Guidelines Issued 74 Awarded Patents 74 Help Detect 74 Announce Collaboration 74 Develops Novel 74 Widely Used 74 Nicotine Vaccine 74 Slow Progression 74 Patient Treated 74 Receives Clearance 74 Helps Prevent 74 Unveils Groundbreaking 74 Study Casts Doubt 74 Announce Merger Agreement 74 Initiates Phase III 74 Drug Combo 74 Can Detect 74 Pediatric Patients 74 Pooled Analysis 74 Demonstrates Statistically Significant 74 Submits Response 74 Commercialize 74 FDA Approves Drug 74 FDA Approval 74 Patients Receiving 74 Reports Positive 74 Investigational Treatment 74 Signs Licensing Agreement 74 Being Studied 74 Antiviral Drugs 74 Effective Than 74 Combination Treatment 74 Teva Provides Update 74 Study Shows Benefits 74 Mouse Model 74 Fungal Infections 74 Receives CE 74 Files Investigational 74 Issued Patent 74 Prostate Cancer Patients 74 Immune Cells 74 Discontinues 74 Generic Version Of 74 Terminate Merger Agreement 73 Osteoporosis Drugs 73 Introduces Breakthrough 73 Presents Positive Preclinical 73 Antitumor Activity 73 Preclinical Data 73 Significantly Reduced 73 Recall Issued 73 Trial Evaluating 73 Therapy Reduces 73 Signs License Agreement 73 Combo Therapy 73 Commercially Available 73 FDA Warns Against 73 Expands Portfolio 73 Collaborators Publish 73 Reports Preclinical Data 73 Develop Innovative 73 Could Revolutionize 73 Phase IIa Clinical Trial 73 Asthma Treatment 73 Slows Progression 73 Initiate Phase III 73 Phase IIb Clinical Trial 73 Announces Publication 73 FDA Approves Generic 73 Announce Availability 73 Patients Suffering 73 Vaginal Gel 73 Immunomedics Announces 73 Receives Favorable 73 Commercialize Novel 73 Vaccine Candidate 73 Circulating Tumor Cells 73 Drug Prevents 73 Insulin Pen 73 Releases Next Generation 73 Stem Cell Treatment 73 Delivers Next Generation 73 Patients Treated 73 Dramatically Increases 73 Expands Capabilities 73 Voluntarily Withdraws 73 Guidelines Recommend 73 Study Indicates 73 Treating Chronic 73 Obtains License 73 Genes Linked 73 Announces Positive 73 Develops Innovative 73 Unveils Revolutionary 73 Introduces Unique 73 Helps Identify 73 Inhibits 73 Therapy Improves 73 Provide Comprehensive 73 Scientists Develop 73 Complicated Skin 73 Diabetic Foot Ulcer 73 Anticancer Activity 73 Seasonal Influenza Vaccine 73 Begin Clinical Trials 73 Demonstrates Efficacy 73 Study Confirms 73 Survival Benefit 73 Tumor Targeting 73 Drug Maker 73 Oral Calcitonin 73 Kidney Function 73 Settle Patent Litigation 73 Extends Collaboration 73 Non Invasive 73 Completes Dosing 73 Earns Milestone Payment 73 Vitrasert R 73 Obtains Exclusive License 73 Acquires Exclusive 73 Adjuvant Chemotherapy 73 Obtains Approval 73 CDC Recommends 73 Antifungal 73 Demonstrated Significant 73 Heart Stents 72 Long Term Efficacy 72 Intravenous Formulation 72 Vaccine Shows Promise 72 Improve Survival 72 Demonstrates Superior 72 Could Save Lives 72 Hypertensive Patients 72 Treatment Shows Promise 72 Patients Enrolled 72 Help Diagnose 72 Anti Inflammatory 72 Significantly Improved 72 Launches Next Generation 72 Systemic Delivery 72 Phase 2a Trial 72 Supplemental Biologics License Application 72 Previously Treated 72 Announces Successful Completion 72 Contrast Enhanced 72 Lowers Blood Pressure 72 Helps Detect 72 Infected Patients 72 Dry Powder Inhaler 72 Board Authorizes 72 Investigational Oral 72 Study Evaluates 72 Disease Modifying 72 Successfully Tested 72 Reduces Mortality 72 Potentially Fatal 72 Drug Coated Stent 72 Anti Tumor Activity 72 Detect Cancer 72 Gene Variant 72 Virus Linked 72 Treated Patients 72 Presents Preclinical 72 Kinase Inhibitor 72 Is Well Tolerated 72 Smallpox Vaccine 72 Strengthens Position 72 Synthetic Peptide 72 Device Helps 72 Announces Presentation 72 Adjunctive Therapy 72 Heart Failure Patients 72 Recombinant Human 72 Kidney Transplant Patients 72 Lung Cancer Survival 72 Contrast Agents 72 Shingles Vaccine 72 HCV Protease Inhibitor 72 Could Prevent 72 Announce Definitive Agreement 72 Device Maker 72 Newly Identified 72 Initiates Phase 72 Study Proves 72 Cancer Treatments 72 Low Dose 72 Schizophrenia Drug 72 Phase 1b Clinical Trial 72 Eliminates Need 72 Shown Effective 72 Severe Sepsis 72 Minimally Invasive Procedure 72 Announces Favorable 72 Exercises Option 72 Demonstrates Potent 72 Heartburn Drugs 72 Mg Usa 72 Unveils Latest 72 Demonstrates Ability 72 Provides Guidance 72 Gene Mutation 72 Acquire Privately Held 72 Cholesterol Lowering 72 Interferon Alpha 72 Prophylactic Treatment 72 Flagship Product 72 Unveils Next Generation 72 Anti Nausea 72 Cholesterol Drugs 72 Successfully Completes Tender Offer 72 Fast Track Status 72 Lung Cancer Patients 72 Strengthens Balance Sheet 72 Protease Inhibitor 72 Milestone Payment From 72 Immune Responses 72 Cell Transplants 72 Prognostic Value 72 Amends Agreement 72 Therapeutic Vaccine 72 Eases Pain 72 Rotavirus Vaccine 72 Vascular Grafts 72 Tablet Formulation 72 Oral Interferon 72 Anemia Drugs 72 Pharmaceuticals Initiates 72 Investigational Agent 72 Advanced Colorectal Cancer 71 Weight Loss Drug 71 Introduces Enhanced 71 Prolongs Life 71 Introduces Powerful 71 Confirms Efficacy 71 Protein Linked 71 Shows Statistically Significant 71 Regenerative Cells 71 Companion Diagnostic 71 Treatment Naïve 71 Diet Pill 71 Spinal Fusion 71 Study Validates 71 Allergic Reactions 71 Epilepsy Drugs 71 gets USFDA nod 71 Anti Inflammatory Drug 71 Settle Patent Dispute 71 Beta Blocker 71 Further Validates 71 Completes Tender Offer 71 Genetic Tests 71 Potentially Deadly 71 Expands Scope 71 Provides Update Regarding 71 Pain Relievers 71 Showed Significant 71 Initiate Phase 71 FDA APPROVES 71 Unveils Innovative 71 Randomized Trials 71 Fracture Risk 71 Antibiotic Resistant 71 Monoclonal Antibody 71 Commence Phase 71 Pivotal Phase III 71 Medoxomil 71 Improved Survival 71 Introduces Innovative 71 Statin Drugs 71 Genes Associated 71 Well Tolerated 71 Inhaled Insulin 71 Node Positive 71 IND Filing 71 Myeloma Patients 71 Launches Unique 71 Announces Dismissal 71 REMINDER ORLive Presents 71 Accelerate Commercialization 71 Predict Risk 71 Successfully Completed 71 Previously Untreated 71 Viral Load 71 Gene Linked 71 Q4 Loss Narrows 71 Resubmits 71 Oral Fluid 71 Metastatic Melanoma 71 Helps Reduce 71 Q3 Loss Narrows 71 Bird Flu Vaccine 71 Completes Merger With 71 Revises FY# Outlook 71 NICE Recommends 71 Achieves Unprecedented 71 HER2 Positive Breast Cancer 71 Sinus Infections 71 Obtains Exclusive Rights 71 Gene Variants 71 Inhaled Corticosteroids 71 Receives Complete Response 71 Absorbable 71 Patents Covering 71 Unveils Breakthrough 71 Hemodialysis Patients 71 Silicone Breast Implants 71 Jumps Higher 71 Demonstrates Sustained 71 Helps Diagnose 71 Bone Metastases 71 Pre Cancerous 71 Boosts Productivity 71 Virus Infection 71 Strengthens Leadership 71 Oral Fingolimod 71 Study Compares 71 Q1 Loss Narrows 71 Polymerase Inhibitor 71 Provides Comprehensive 71 Therapeutic Antibody 71 Therapy Shows Promise 71 Preclinical Study 71 BioElectronics Announces 71 vapreotide acetate 71 Novel Treatments 71 Receive Milestone Payment 71 Rat Poison Found 71 Stomach Ulcer 71 Pandemic Flu Vaccine 71 Advanced Prostate Cancer 71 Q3 Loss Widens 71 Receives Approval 71 Mg Uk 71 Continues Momentum 71 Confirmatory Phase 71 Results Confirm 71 Tissue Engineered 71 Combination REOLYSIN R 71 Announces Issuance 71 COMUNICADO 71 Breast Cancer Treatment 71 Ebola Vaccine 71 Study Shows Promise 71 Combination Therapy 71 Premenopausal Women 71 Researchers Identify 71 Secures Patent 71 Breast Cancer Cells 71 Provides Shareholder 71 Pivotal Phase 71 includes Dideco CarboMedics 71 Announces Voluntary Recall 71 Settles Patent Dispute 71 Phase 2a Clinical Trial 71 Announces Availability 71 Orally Active 71 Tyrosine Kinase Inhibitor 71 Hematology Molecular Pathology 71 Enters Agreement 71 Therapeutic Efficacy 71 Therapeutic Competitors Report 71 Novel Compounds 71 Platform Enables 71 Successfully Completes 71 Prostate Biopsy 71 Reacquires 71 Rheumatoid Arthritis Patients 71 Elderly Patients 71 Obesity Linked 71 Chronic Hepatitis C 71 Finalizes Acquisition 71 Sirolimus Eluting Stent 71 Genotyping Test 71 Novel Method 71 Licensing Pact 70 Study Shows Significant 70 Q2 Loss Narrows 70 Urine Test 70 Obtains CE Mark 70 TNF Blockers 70 External Beam 70 Cypher Sirolimus 70 Imaging Technique 70 Liver Tumors 70 Genes Identified 70 Voluntarily Withdraw 70 Respiratory Virus 70 Breast Cancer Patients 70 Showcases Innovative 70 Initiates Phase 2b 70 Chronic Sinusitis 70 Plaque Psoriasis 70 Critically Ill Patients 70 Issues Guidance 70 Anti Tumor 70 Acne Medication 70 Nail Fungus 70 Acquire Assets 70 Endometrial Cancer 70 Contaminant Found 70 Buy Privately Held 70 Novel Inhibitor 70 Anemia Drug 70 Prostate Cancer Treatment 70 Reports Receipt 70 Vaccine Prevents 70 Blood Clotting 70 Improves Efficiency 70 Receives Certification 70 Fortifies 70 Terminates Contract 70 Technol 70 Vaccine Protects Against 70 Canaccord Genuity Reiterates Buy 70 Fully Automated 70 First Patient Dosed 70 JAK2 Inhibitor 70 Naive Patients 70 Achieves Positive 70 Hepatitis C Genotype 70 Licenses Patents 70 Identifies Potential 70 Statistically Significant 70 Secures Financing 70 Adjuvanted 70 Doctors Warn 70 Transplant Patients 70 Crit Rev 70 Receives Favorable Ruling 70 Novel Protein 70 Highly Accurate 70 Q2 Loss Widens 70 Technological Advances 70 Oral Mist 70 Commonly Used 70 Awarded Qualifying Therapeutic 70 Neoadjuvant Chemotherapy 70 Explore Strategic Alternatives 70 Unfractionated Heparin 70 Eur J 70 Clinical Outcome 70 Genes Involved 70 Announce Receipt 70 Delivers Breakthrough 70 Announces Discontinuation 70 Generic Protonix 70 Novel Antibiotic 70 Being Evaluated 70 Drug Eluting 70 Strongly Linked 70 AVI BioPharma Announces 70 Novel Compound 70 Newly Diagnosed Multiple Myeloma 70 Files Shelf Registration Statement 70 Antidepressants Linked 70 Patent Infringement Suit 70 Genes Predict 70 Hepatitis B Vaccine 70 Univest Corporation Declares 70 Levels Linked 70 Attenuates 70 Initiates Voluntary Recall 70 Hormone Refractory Prostate Cancer 70 Controlled Study 70 Q1 Loss Widens 70 CysDisplay R 70 Reconfirms 70 Significantly Improve 70 Board Unanimously Rejects 70 Diet Linked 70 Cocaine Addiction 70 First Patient Enrolled 70 Unveils Newest 70 Interferon Gamma 70 Induces 70 Recall Expanded 70 Lifts FY# Outlook 70 Recombinant Protein 70 ANDA Filing 70 Deep Venous Thrombosis 70 Protein Expression 70 Transdermal Delivery 70 TM Aganocide 70 Pivotal Clinical Trial 70 Deliver Powerful 70 Signs Merger Agreement 70 Chronic Hepatitis B 70 Subsidiary Enters 70 Tumor Growth 70 Lowers Cholesterol 70 Study Identifies 70 Receives Approvals 70 Hernia Repair 70 Treatment Regimen 70 Anti Clotting Drug 70 Mutually Agree 70 Secures Funding 70 Lupus Nephritis 70 Reduced Risk 70 Novartis Novo Nordisk 70 Spectrum Pharmaceuticals Announces 70 Researchers Develop 70 Receives Notification 70 Knee Osteoarthritis 70 Sirolimus Eluting 70 Outperforms 70 Settles Litigation 70 Achieves Significant 70 Wins Patent Infringement 70 Dose Escalation 70 Announces Definitive Agreements 70 Biogen Genentech 70 Demonstrates Long Term 70 Anticancer Drug 70 Postmenopausal Osteoporosis 70 Gets Approval 70 Significant Improvement 70 Adenoma 70 Release Capsules 70 Receptor Agonist 70 Implantable Device 70 Clinically Proven 70 STERIS Corporation Announces 70 Prostate Tumors 70 Bronchodilator 70 Impairs 70 Receives Unsolicited 70 Pivotal Trial 70 Unsolicited Proposal From 70 Demonstrates Improved 70 Sagent Pharmaceuticals Announces 70 Reduce Risk 70 Receives Funding 70 Net Loss Narrows 70 Adjuvant Therapy 70 MarketsandMarkets Global 70 Inks Licensing Deal 70 Refractory Hodgkin Lymphoma 70 Embolic Protection 70 Aggressive Prostate Cancer 70 Spinal Implant 70 Receives Regulatory 70 Hormone Receptor Positive 70 Maven Semantic 70 Human Monoclonal Antibody 70 Recurrent Breast Cancer 70 Gene Expression Analysis 70 Microwave Ablation System 70 Patent Lawsuit 70 Suppresses 70 Nasal Powder 69 VIVUS Announces 69 Unveils Expanded 69 Obese Patients 69 Updates Guidance 69 Overactive Bladder 69 Files Patents 69 Help Predict 69 Drug Coated Stents 69 Receives NASDAQ 69 Bullish Engulfing Pattern 69 Announces Effective Date 69 Merge Healthcare Announces 69 Inc Therapeutic Competitors 69 Serious Side Effects 69 Gum Disease 69 Broadens Its 69 Achieves Record Sales 69 Testosterone Patch 69 Announces Enhancements 69 Jointly Announce 69 Predict Dementia 69 Muscle Wasting 69 Strengthens Its 69 Biomarker Study 69 Offers Unprecedented 69 Q4 Loss Widens 69 Weight Loss Pill 69 Clinical Trial Data 69 platform HDL Mimetic 69 Hydrochlorothiazide Tablets 69 Humanized Anti 69 Bioresorbable 69 Begins Clinical Trial 69 Expand Relationship 69 Cases Linked 69 Treatment Experienced 69 Jointly Develop 69 Flamel Technologies Announces 69 Plus Ribavirin 69 Increased Mortality 69 Significant Improvements 69 Completes Successful 69 Syneron logo 69 Amplifies 69 Technicals Showing Bearish 69 Therapeutic Vaccines 69 Results Indicate 69 Pharmacokinetic Study 69 Male Contraceptive 69 Cervical Cancer Vaccine 69 Disease Progression 69 BIOLASE Announces 69 Measurement Instruments 69 Announce Initiation 69 Guides Inline 69 Deaths Linked 69 Injectable Gel 69 Conjugate 69 Testosterone Gel 69 Study Reinforces 69 Inherited Diseases 69 Successfully Concludes 69 Wound Dressing 69 Receives Tentative FDA 69 Diagnostic Tools 69 Enhances User Experience 69 Hip Prosthesis 69 Regains NASDAQ 69 Efficacy Trial 69 Protein Biomarker 69 Announce Launch 69 Estrogen Therapy 69 Receives Subpoena 69 siRNA Delivery 69 Skin Lesions 69 Hand Sanitizers 69 hc2 High Risk 69 Ultrasensitive 69 License Pact 69 PPD Declares 69 Announce Agreement 69 Assay Kits 69 Blood Glucose Testing 69 Attains 69 R MSCRAMM 69 visit www.genenews.com 69 #-# Full Text 69 Reduces Size 69 Blood Vessels 69 Helps Ease 69 Launches Innovative 69 Ondansetron Orally Disintegrating Tablets 69 Relapsed Refractory 69 topical gel formulation 69 Liver Transplant Patients 69 Q1 Profit Surges 69 Daytradersdigest.com 69 Q2 Adj 69 Wound Dressings 69 Signs Agreements 69 Gene Variation 69 Inhaled Nitric Oxide 69 Phase III Trials 69 Secondary Hyperparathyroidism 69 Breast Biopsy 69 Bacterial Infection 69 Delivers Unprecedented 69 Hepatitis C Treatment 69 Diabetic Neuropathy 69 Develops Breakthrough 69 Advisers Urge 69 Antibiotic Use 69 RNAi Therapeutic 69 Study Sheds Light 69 Sangamo BioSciences Announces 69 Enteral Feed Devices 69 Small Molecule 69 Achieves Certification 69 Ultra Sensitive 69 Announces Poster Presentations 69 Voluntarily Recalls 69 Oral Formulation 69 Impotence Drug 69 Regenerative Cell 69 PerkinElmer Introduces 69 markets COLAZAL 69 Relieves Pain 69 Postmenopausal Women 69 Cancer Cells 69 Migraine Treatment 69 Gets Clearance 69 Hormone Therapy 69 Topical Gel 69 Brain Metastases 69 FOR WELL BEING 69 Momentum Continues 69 Debuts Next Generation 69 Doubles Capacity 69 Curr Opin 69 For Undisclosed Terms 69 Urinary Tract Infections 69 Extends Tender Offer 69 Immunosuppressant 69 Mouse Models 69 Report Analyzes 69 Scientists Uncover 69 Healthbeat Report 69 Renal Cancer 69 Sinks Lower 69 R Saizen R 69 Treatment Naïve Patients 69 SIX RO ROG 69 Glucose Monitor 69 Further Strengthens 69 Helps Improve 69 Dose Ranging Study 69 Eradicates 69 Successfully Complete 69 Metastatic Colorectal Cancer 69 Immune Cell 69 Extends Leadership 69 Molecular Diagnostic 69 Revolutionizes 69 Extends Reach 69 Patent Infringement Lawsuit 69 Lowers Guidance 69 Pain Medications 69 Delivers Enhanced 69 Achieves Prestigious 69 Endovascular Treatment 69 Clinical Evaluation 69 Lymph Node 69 Artificial Skin 69 Renal Cell Carcinoma 69 Technicals Showing Bullish 69 Anticancer Agent 69 Veeco Introduces 69 Robotic Assisted 69 Improves Patient 69 Cuts Costs 69 Increased Risk 69 Arterial Disease 69 Modulates 69 Vildagliptin 69 Malaria Vaccine 69 Lanthanum Carbonate 69 Clinically Tested 69 STELARA TM 69 Provides Unprecedented 69 Forecast Quick Facts 69 Chemotherapy Regimen 69 Flu Vaccines 69 Little Colds Decongestant Plus 69 Prevent Stroke 69 Novel Therapeutic 69 Amend Merger Agreement 69 Myocardial Perfusion Imaging 69 Aztreonam Lysine 69 Uracyst R Test 69 Misonix Announces 69 Dialysis Patients 69 Breast Tumors 69 Multiple Myeloma Patients 69 Expands Capacity 69 Announces Stockholder Approval 69 Announces Definitive Agreement 69 Acquires Assets 69 JAK Inhibitor 69 Extend Collaboration 69 Nasal Sprays 69 Accurately Predicts 69 Recommends Approval 69 Tezampanel 69 Nanoemulsion 69 Releases Enhanced 68 Inflammatory Disease 68 Prevent Spread 68 Reaffirms FY# Outlook 68 Int J 68 Obtains Patent 68 MEDW 68 Image Guided 68 Resistant Hypertension 68 INDUSTRY ASSESSMENTS 68 Completes Installation 68 Increases Productivity 68 Percutaneous Tibial Nerve Stimulation 68 David Rapperport Quest 68 TB Vaccine 68 Completes Transition 68 Tuberculosis Vaccine 68 Drug Eluting Coronary Stent 68 Virus Vaccine 68 High Growth Forecasted 68 Parathyroid Hormone 68 Underscores Importance 68 CT Angiography 68 Antimicrobial Coating 68 Milestone Payments 68 Announces Divestiture 68 Refocuses 68 Appoints Experienced 68 AUDIO PROVIDED BY 68 Vitro Activity 68 Alert Technicals Showing Bullish 68 Sublingual 68 Detect Breast Cancer 68 Total Knee Arthroplasty 68 Alert Technicals Showing Bearish 68 Provides Updates 68 Bosutinib 68 R famotidine 68 Triaminic Infant & 68 Backs FY# Outlook 68 Randomized Clinical Trials 68 Launches Enhanced 68 Announce Settlement 68 Exposure Linked 68 Taglich Brothers Initiates Coverage 68 Novel Vaccine 68 Million Milestone Payment 68 Restructures Operations 68 Derma Sciences Announces 68 Artery Disease 68 Offers Affordable 68 Study Pinpoints 68 Lower Blood Pressure 68 Lung Tumors 68 Long Lasting 68 Trial Halted 68 Fewer Side Effects 68 Benign Prostatic Hyperplasia 68 Enters Into Licensing Agreement